$0.70
3.38% yesterday
Nasdaq, Jan 06, 10:00 pm CET
ISIN
IL0011651580
Symbol
PRFX

PainReform Ltd Stock News

Neutral
GlobeNewsWire
one day ago
New lifecycle-wide audit platform provides complete data coverage, advanced diagnostics, and rapid turnaround, supporting investors, operators, insurers and lenders across commissioning, underperformance, warranty expiry, and asset transactions New lifecycle-wide audit platform provides complete data coverage, advanced diagnostics, and rapid turnaround, supporting investors, operators, insurers...
Neutral
GlobeNewsWire
27 days ago
TEL AVIV, Israel, Dec. 10, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) today announced that its pharmaceutical division has completed an R&D assessment of LayerBio's proprietary drop-less, sustained-release ocular drug-delivery platform.
Neutral
GlobeNewsWire
about one month ago
Development plan positions OcuRing™-K for advancement in the fast-growing, multi-billion-dollar global cataract surgery market Development plan positions OcuRing™-K for advancement in the fast-growing, multi-billion-dollar global cataract surgery market
Neutral
GlobeNewsWire
about 2 months ago
TEL AVIV, Israel, Nov. 12, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) today announced that DeepSolar, its solar energy business unit developing next-generation AI analytics, has advanced the development of its proprietary automated reporting engine, designed to transform how solar-asset performance is analyzed, understood, and communicated.
Neutral
GlobeNewsWire
2 months ago
TEL AVIV, Israel, Nov. 05, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), today announced that DeepSolar, its solar energy business unit developing next-generation AI-driven solar analytics, was recently featured in a Watchlist Interview produced in collaboration with The Market Link, highlighting its participation in the NVIDIA Connect program.
Neutral
GlobeNewsWire
3 months ago
TEL AVIV, Israel, Oct. 01, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), a specialty pharmaceutical company focused on the reformulation of established therapeutics and commercialization of AI-driven solar analytics technologies, today provided a business update for the six months ended June 30, 2025.
Positive
Finbold
5 months ago
Shares of Israel-based pharmaceutical company PainReform (NASDAQ: PRFX) jumped nearly 130% on Tuesday after its renewable energy arm, DeepSolar, was accepted into the Nvidia (NASDAQ: NVDA) Connect Program.
Neutral
GlobeNewsWire
5 months ago
Acceptance to NVIDIA Connect Program offers access to unique tools for the development of DeepSolar's nextgen, AI-driven, solar forecasting platform to improve weather prediction accuracy by up to 50% and optimize energy asset performance Acceptance to NVIDIA Connect Program offers access to unique tools for the development of DeepSolar's nextgen, AI-driven, solar forecasting platform to improv...

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today